Lenalidomide and subsequent TP53-mutated myeloid neoplasms, abnormal uterine bleeding after VTE, and novel tri-specific antibody for B-ALL
Blood Podcast
00:00
Introduction
The first perspective study to evaluate abnormal uterine bleeding in women's starting anti-coagulation for venous thromboembolism. An optimized tri-specific antibody that overcomes immune escape and enhances therapeutic efficacy in a patient-derived xenograft model of B-cell ALL. This strategy could help overcome the challenges of tumor resistance seen with bi-specific antibody treatment.
Transcript
Play full episode
